/explore

Click through on any links that interest you or select the planets on the right to continue exploring the Outer Web.
You are here

 www.theatlantic.com
Pfizer Vaccine Full Approval: Why the FDA Took So Long - The Atlantic
| | www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
2.2 parsecs away

Travel
| | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV
| | blogs.bmj.com
Peter Doshi: Pfizer and Moderna's "95% effective" vaccines-we need more details and the raw data - The BMJ
2.1 parsecs away

Travel
| | On 5 February 2021 we published a clarification to this piece. It is available here. Five weeks ago, when I raised questions about the results of Pfizer's and Moderna's covid-19 [...]More...
| | donshafi911health.wordpress.com
Peter Doshi: Pfizer and Moderna's "95% effective" vaccines-we need more details and the raw data - The BMJ - donshafi9?1?1?
2.0 parsecs away

Travel
| | Peter Doshi: Pfizer and Moderna's "95% effective" vaccines-we need more details and the raw data January 4, 2021 Five weeks ago, when Iraised questionsabout the results of Pfizer's and Moderna's covid-19 vaccine trials, all that was in the public domain were thestudy protocolsand afewpressreleases. Today, twojournalpublicationsand around 400 pages of summary data are available in...
| | blog.fellstat.com
What to Expect When You Are Expecting the Delta Covid-19 Variant - Fells Stats
21.3 parsecs away

Travel
| [AI summary] The article discusses the Delta variant of SARS-CoV-2, its increased infectiousness compared to the original strain, global spread, vaccine efficacy against it, and potential economic and humanitarian impacts.